Futura Medical is the developer of innovative sexual health products, including lead product Eroxon®. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Our lead product is Eroxon®a clinically proven breakthrough treatment for erectile dysfunction
Futura has two new products in its development pipeline, Eroxon® Intense and WSD4000 for the treatment of sexual dysfunction in men and women.
Futura has a proven track record in delivery and completion of Research & Development projects up to value inflection points at which they are suitable for commercialisation partners.
WEBCASTS
Videos and webcasts
Shareholder centre
This section contains the latest RNS, news and videos.
Change of Broker
Results for the Year ended 31 December 2024
Notice of Results and Investor Presentation
Read more
9.25p (GB)
Change: -0.10 Last updated: 21:30
Share price information delayed at least 15 minutes
Download our Interim Results 2024
15 April 2025
04 November 2024
©2025 Futura Medical